Clinical application of detection of Warfarin-related gene polymorphisms by DNA sequencing
WU Wei;LI Yan;TONG Yong-qing;ZHENG Hong-yun;BAO An-yu;GU Jian

..............page:1016-1020

Value of serum IgG4 in diagnosis of IgG4-related disease and in differentiation from rheumatic diseases
HE Zheng-wen;TANG Gu-sheng;LU Qiong;SHEN Qian

..............page:1029-1033

The detection of BRAF mutations and its clinical significance in colorectal cancer patients
SHEN Yin-chen;WANG Jian-fei;YANG Hong-ying;WANG Fang;SHI Yuan-kai;HAN Xiao-hong

..............page:993-999

Progress in the detection of Kras, EGFR, BRAF mutations and its clinical application
SUN Yan-li;LI Jin-ming

..............page:971-977

Advancement on the pharmacogenomics of immunosuppressant
LIAO Yun;LI Yi;CAI Bei;WANG Lan-lan

..............page:978-985

The importance of quality assurance in laboratory test for personalized medicine
ZHANG Rui;LI Jin-ming

..............page:963-966

Establishment of a novel mutant-enriched liquid chip technology for detecting EGFR mutations in plasma of patients with non-small cell lung cancer
ZHENG Li-xia;HE Chen;LIU Ming;ZHOU Bei-xian;XU Jun

..............page:986-992

Establishment of a novel ring primer real-time PCR for quantification of the mRNA expression levels of HER2 gene
LI Yi;LIU Guo-yan;ZHANG Huan-jing;ZHENG Li-mou;ZENG Ji-meng

..............page:1000-1005

Adapting the demands of tumor individualized therapy and promoting the development of molecular diagnostic career in China
SHI Yuan-kai

..............page:961-962

fan nai yao bao man bu dong gan jun zhong fa xian parc ji yin xin bian yi xing
geng xian long ; wang chun xin ; xu ya feng ; chen guo qian ; zhao zuo ; zhou li zhen ; mi zu huang

..............page:1048-1050

wai zhou xue xun huan zhong liu xi bao de jian ce ji qi lin chuang yi yi
wei zuo ; han xiao hong

..............page:1053-1056

xin xi dong tai

..............page:985,999,1028,1052,1056

To establish a method for detecting genetic polymorphism of CYP2C9 1075A ＞ C and VKORC1-1639 G ＞ A and evaluate the correlation of SNP with Warfarin dose
ZHAO Lei;JIA Mei

..............page:1010-1015

Performance evaluation of nine commonly used urine albumin assay systems
WANG Xue-jing;XU Guo-bin;ZHANG Jie

..............page:1038-1044

Antimicrobial resistance surveillance of gram-positive cocci isolated from 14 hospitals in China in 2011
GUO Yu;WANG Hui;ZHAO Chun-jiang;WANG Zhan-wei;ZHANG Fei-fei;CAO Bin;HU Bi-jie;LIAO Kang;MEI Ya-ning;YANG Qing;XU Ying-chun;CHEN Min-jun;HU Zhi-dong;SUN Zi-yong;ZHANG Li-yan;YU Yun-song;CHU Yun-zhuo;XU Xiu-li;NI Yu-xing

..............page:1021-1028

Diagnostic value of Golgi-73 and AFP alone or combination in primary hepatocelluar carcinoma
YANG Ying;MU Ni re · ma he su ti;BAO Yong-jiang;ZHAO Hua-rong;MAO Rui;XIAO Lei;ZHANG Yue-fen;BAO Yong-xing

..............page:1034-1037

Pharmacogenomics and individual therapy of immunosuppressive drugs in transplant recipients
WANG Lan-lan

..............page:967-970

The signification and method of HBeAg gray zone setting and its cut-off verification in chemiluminescent assay
AN Cheng;CHENG Shi;LI Jie;LIU Gui-jian

..............page:1045-1047

Application of gene sequencing in detection of BRCA1/2 gene mutations in breast cancer patients and risk assessment
WU Ze-gang;LI Yan;TONG Yong-qing;ZHENG Hong-yun

..............page:1006-1009

tong guo fei pao guan xi ye biao ben jian chu fei fen lei yuan xian chong bing yi li bing wen xian fu xi
zhang feng ; guo ye ; wang geng ; cui wei

..............page:1051-1052